Peptide-powered wellness.
Direct-pay telehealth, 48 states + DC.
Medical Weight Loss
Physician-supervised evaluation for a GLP-1 receptor agonist option.
Overview
Semaglutide is a GLP-1 receptor agonist. Several FDA-approved branded semaglutide products exist; TelePeptide does not sell or distribute branded products. Where clinically appropriate after individualized medical evaluation, a licensed physician may prescribe a compounded preparation containing semaglutide tailored to the specific patient. The compounded preparation is dispensed by a licensed 503A or 503B compounding pharmacy. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of any branded product, and are not represented as therapeutically equivalent.
Administration
If prescribed, self-administered per the physician's instructions.
Frequency
As directed by the prescribing physician.
Program Track
Medical Weight Loss
Pricing
from $169 /mo
Annual prepay rate · monthly billing $199/mo · all-inclusive
How It Works
Semaglutide is a synthetic peptide that acts at the GLP-1 receptor. Receptor activation may stimulate insulin secretion, suppress glucagon, slow gastric emptying, and act on appetite-regulating centers in the brain. Mechanism information is provided for general education; whether semaglutide (in any form) is clinically appropriate for an individual patient is a determination made by the prescribing physician based on full medical history.
Benefits
Eligibility
Adults seeking physician-supervised medical weight-management evaluation. Eligibility, dose, and form are determined individually by your prescribing physician based on full medical history. Not appropriate for patients with certain thyroid conditions (including a personal or family history of medullary thyroid carcinoma or MEN2 syndrome), pancreatitis history, or other contraindications.
Clinical supervision required. Eligibility for this program is determined by your prescribing physician based on individual medical history. Not all patients will qualify.
FAQ
No. Compounded preparations are not FDA-approved drugs, are not generic versions of branded medications, and are not represented as therapeutically equivalent to any FDA-approved product. Compounded medications are prepared by licensed 503A or 503B pharmacies under specific federal rules. Whether a compounded preparation is appropriate for a given patient is an individualized clinical decision made by the prescribing physician.
Both forms contain semaglutide as the active ingredient. The clinical choice between forms is made by your prescribing physician based on individual medical history, tolerance, and clinical fit. Compounded preparations are not FDA-approved drugs and are not represented as therapeutically equivalent to any FDA-approved branded product.
The most common side effects are nausea, vomiting, constipation, and diarrhea — particularly during dose escalation. These typically subside as the body adjusts. Your physician will titrate your dose to minimize side effects.
Your physician will develop a maintenance plan with you. Some patients taper to a lower maintenance dose; others transition to peptide wellness programs for ongoing metabolic support. This is planned collaboratively.
Complete a brief online intake — a licensed physician will review your goals and confirm eligibility.